PMI Impact Malaria
PMI Impact Malaria was a USAID-funded global health service delivery project led by PSI, supporting 19 National Malaria Control Programs across sub-Saharan Africa and the Greater Mekong Subregion to strengthen malaria diagnosis, treatment, and drug-based prevention. The project closed on May 31, 2024.
- Company typePrivate
- Founded2018
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PMI Impact Malaria does
PMI Impact Malaria was a global health service delivery project established in April 2018 as the flagship global service delivery project of the U.S. President's Malaria Initiative (PMI), funded by USAID and implemented by Population Services International (PSI) in partnership with Jhpiego, MCD Global Health, and the Malaria Elimination Institute at UCSF. The project supported 19 National Malaria Control Programs and Ministries of Health across sub-Saharan Africa and the Greater Mekong Subregion, focused on strengthening malaria diagnosis, treatment, and drug-based prevention for children under five and pregnant women.
Its core methodology was OTSS+ (Outreach, Training and Supportive Supervision Plus), a facility-level quality improvement approach combining on-site supportive supervision, troubleshooting, and on-the-job training. Supporting digital tools included the OTSS+ Digital Data Entry Platform for real-time facility-level data capture, the PMI Impact Malaria Data Hub for cross-country monitoring and decision support, and digitized global packages of OTSS+ checklists. Beyond OTSS+, the project delivered complementary service delivery programs including Integrated Community Case Management (iCCM) for community-based childhood illness care, Seasonal Malaria Chemoprevention (SMC) campaigns delivering antimalarial medicines to children in the Sahel, Malaria in Pregnancy (MIP) prevention through IPTp, and Therapeutic Efficacy Studies (TES) across 40 sites in 9 countries. The project produced 10 peer-reviewed manuscripts in an AJTMH Special Supplement.
The project operated on a grant-funded, non-commercial model with no products sold and no pricing structure. All funding flowed from USAID through PMI, and the project provided technical assistance and capacity building at no cost to partner governments and health facilities. Activities were delivered through partnership agreements with country-level governments and went-to-market through direct engagement with NMCPs (described as a sales-led/B2G field motion combined with an event-driven thought leadership motion at global health conferences such as ASTMH). The project officially closed on May 31, 2024, after over six years, with operational continuity transferred to the successor PMI REACH project.
PMI Impact Malaria firmographics
Firmographics- Name
- PMI Impact Malaria
- Legal name
- PMI Impact Malaria
- Website
- https://impactmalaria.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- PMI Impact Malaria was a USAID-funded global health service delivery project led by PSI, supporting 19 National Malaria Control Programs across sub-Saharan Africa and the Greater Mekong Subregion to strengthen malaria diagnosis, treatment, and drug-based prevention. The project closed on May 31, 2024.
- Ownership category
- akta.pro rank
PMI Impact Malaria industry classification
Industry- Product category
- Global Health Services / Malaria Control Programs
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Management Services (8741)
- akta.pro primary industry
- Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)
- akta.pro secondary industry
- Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA)
Keywords
Where PMI Impact Malaria is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PMI Impact Malaria business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- USAID/U.S. President's Malaria Initiative Funding: PMI Impact Malaria was fully funded by the United States Agency for International Development (USAID) as the flagship global service delivery project of the U.S. President's Malaria Initiative (PMI). The project received funding from 2018 to 2024, with the project officially closing on May 31, 2024. The project was led by Population Services International (PSI) in partnership with Jhpiego, MCD Global Health, and MEI at UCSF. No commercial revenue was generated.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
PMI Impact Malaria product offering
Product offeringCore offering
PMI Impact Malaria is a global health service delivery project that provides technical and programmatic assistance to National Malaria Control Programs and ministries of health in 19 countries, strengthening malaria diagnosis, treatment, and drug-based prevention. Its core offering is the OTSS+ (Outreach, Training and Supportive Supervision Plus) quality improvement methodology, supported by integrated programs in community case management (iCCM), seasonal malaria chemoprevention (SMC), and malaria in pregnancy. The project, funded by USAID and led by Population Services International, operated from 2018 until its closure on May 31, 2024.
Product overview
PMI Impact Malaria is a global health service delivery project, not a technology product company. The organization offers a unified portfolio of malaria control interventions rather than a modular software platform. The core methodology is OTSS+ (Outreach, Training and Supportive Supervision Plus), a facility-level quality improvement approach that combines supportive supervision, troubleshooting, and on-the-job training. Supporting service delivery programs include iCCM (Integrated Community Case Management) for community-based childhood illness care, SMC (Seasonal Malaria Chemoprevention) for seasonal prevention campaigns, and Malaria in Pregnancy services. Digital tools include the OTSS+ Digital Data Entry Platform, the PMI Impact Malaria Data Hub, and digitized OTSS+ checklists. The project also conducts Therapeutic Efficacy Studies and publishes research through Special Supplement collections. The project closed on May 31, 2024 after over six years of implementation.
Differentiator
Problem solved
Functional benefit
Products and services
- OTSS+ (Outreach, Training and Supportive Supervision Plus)
- iCCM (Integrated Community Case Management)
- SMC (Seasonal Malaria Chemoprevention) Campaigns
- Malaria in Pregnancy Prevention and Treatment Services
- Therapeutic Efficacy Studies (TES)
Quantifiable outcome
- Health worker competency scores improved from 73% to 93% through OTSS+ in countries implementing the approach
- +6 more outcomes
Companies that use PMI Impact Malaria
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles1 record
PMI Impact Malaria technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
PMI Impact Malaria partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered global partner, country-level technical partner, primary government partners, research collaboration, primary / lead organization and core consortium partner.
- SMC Allianceglobal partnerPMI Impact Malaria joined the SMC Alliance communications subgroup to plan opportunities to showcase the impact of SMC reaching over 50 million children and to support country partners sharing experiences with the global community.
- National Center for Parasitology, Entomology and Malaria Control (Cambodia) and Institut Pasteur du Cambodgecountry-level technical partnerPMI Impact Malaria supported Cambodia's National Center for Parasitology, Entomology and Malaria Control and Institut Pasteur du Cambodge in conducting a study testing a novel point-of-care test for detecting G6PD deficiency and assessing its severity, supporting P. vivax malaria elimination efforts.
- Ministry of Health / National Malaria Control Programs (various countries)primary government partnersPMI Impact Malaria worked in partnership with National Malaria Control Programs and ministries of health across 19 countries (including Burkina Faso, Cameroon, Ghana, Mali, Niger, Rwanda, Sierra Leone, Zambia, DRC, Kenya, Tanzania, Benin, Madagascar, Malawi, Senegal, Laos, Cambodia, Côte d'Ivoire, and others) to strengthen malaria service delivery.
- University Iba Der Thiam of Thiès (Senegal)research collaborationPMI Impact Malaria collaborated with the University Iba Der Thiam of Thiès since 2020 to support Senegal's National Malaria Control Program in conducting a mass drug administration (MDA) study in southeastern Senegal. The partnership demonstrated MDA effectiveness with a 53%+ reduction in malaria incidence, and the university was positioned to support NMCP in scaling up MDA across 3 health districts in Senegal between 2024-2025.
- Population Services International (PSI)primary / lead organizationPSI served as the prime implementing partner and lead organization for PMI Impact Malaria. As the flagship global service delivery project of the U.S. President's Malaria Initiative (PMI), the project was funded and technically assisted by USAID/PMI from 2018-2024. PSI coordinated all consortium activities including technical leadership, strategic direction, and operational management across 19 countries.
- Jhpiegocore consortium partnerJhpiego was a key consortium partner providing technical expertise in malaria service delivery, particularly in malaria in pregnancy (MIP), health worker training, and quality improvement approaches. Jhpiego's Malaria Department Director Gladys Tetteh played a leading role in project technical vision and the global performance monitoring plan.
- MCD Global Health (Medical Care Development International)core consortium partnerMCD Global Health served as a consortium partner providing technical assistance in malaria service delivery. MCD team members contributed to project activities including OTSS+ implementation, publications, and post-project guidance communications.
- Malaria Elimination Institute (MEI) at University of California San Francisco (UCSF)core consortium partnerThe Malaria Elimination Institute at UCSF served as a consortium partner providing technical expertise in malaria elimination, surveillance, and operational research. MEI contributed to elimination-focused activities in the Greater Mekong Subregion and sub-Saharan Africa countries targeting elimination.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
PMI Impact Malaria competitors and assessment
Company assessmentDirect peers
- Jhpiego: Jhpiego was a core consortium partner on PMI Impact Malaria and independently leads malaria in pregnancy and quality improvement work globally; it is a directly comparable technical assistance provider.
- PATH: PATH operates the MACEPA program and broader malaria portfolio covering surveillance, elimination, and vaccine introduction in sub-Saharan Africa and the Mekong, making it a directly comparable implementer and R&D partner.
- Malaria Consortium: Malaria Consortium is a leading non-profit that delivers malaria prevention and treatment programs across sub-Saharan Africa and Asia, including SMC campaigns, iCCM, and health worker training—directly comparable to PMI Impact Malaria's service portfolio.
- Clinton Health Access Initiative (CHAI): CHAI supports malaria programs in dozens of countries through commodity access, case management strengthening, and data analytics, directly overlapping with PMI Impact Malaria's mandate and donor ecosystem.
- Population Services International (PSI): PSI was the prime implementing partner for PMI Impact Malaria and runs its own global health programs across malaria, HIV, and reproductive health in over 40 countries; it is the parent organization and direct operational peer.
- MCD Global Health: MCD Global Health was a core consortium partner for PMI Impact Malaria and independently implements malaria and other public health programs internationally, providing directly comparable technical expertise.
Emerging players
- PMI REACH: PMI REACH is the successor project to PMI Impact Malaria under the U.S. President's Malaria Initiative, taking over country-level malaria service delivery strengthening; it inherits the mandate and is a direct thematic peer.
Broad incumbents
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is the largest multilateral financier of malaria programs globally and supports many of the same country recipients as PMI Impact Malaria; it is a broader incumbent in the same donor ecosystem.
- WHO Global Malaria Programme: The WHO Global Malaria Programme sets normative guidance and country support policies for malaria control and elimination that PMI Impact Malaria's country work directly implemented; a broader incumbent shaping the same operating context.
- Roll Back Malaria Partnership: Roll Back Malaria coordinates global malaria stakeholders, advocacy, and country-level action plans; PMI Impact Malaria participated in its forums and its work directly contributed to RBM partnership goals.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
PMI Impact Malaria social profiles
Digital presencePMI Impact Malaria financial estimates
Financial estimateRevenue estimate
Valuation estimate
PMI Impact Malaria leadership team
Management profileNumber of profiles
Profiles10 records
PMI Impact Malaria funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PMI Impact Malaria M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PMI Impact Malaria
What does PMI Impact Malaria do?
PMI Impact Malaria is a global health service delivery project that provides technical and programmatic assistance to National Malaria Control Programs and ministries of health in 19 countries, strengthening malaria diagnosis, treatment, and drug-based prevention. Its core offering is the OTSS+ (Outreach, Training and Supportive Supervision Plus) quality improvement methodology, supported by integrated programs in community case management (iCCM), seasonal malaria chemoprevention (SMC), and malaria in pregnancy. The project, funded by USAID and led by Population Services International, operated from 2018 until its closure on May 31, 2024.
Is PMI Impact Malaria a public or private company?
PMI Impact Malaria is a private company. It is classified as nonprofit foundation owned and is currently closed.
When was PMI Impact Malaria founded?
PMI Impact Malaria was founded in 2018. It employs 11 to 50 people.
Where is PMI Impact Malaria based?
PMI Impact Malaria is headquartered in Washington, United States, in the North America region.
How does PMI Impact Malaria make money?
One revenue line is on record: USAID/U.S. President's Malaria Initiative Funding.
Who are PMI Impact Malaria's main competitors?
Direct peers on record are Jhpiego, PATH, Malaria Consortium, Clinton Health Access Initiative (CHAI), Population Services International (PSI) and MCD Global Health. PMI REACH is listed as an emerging player. Broad incumbents are The Global Fund to Fight AIDS, Tuberculosis and Malaria, WHO Global Malaria Programme and Roll Back Malaria Partnership.
Does PMI Impact Malaria have an API?
No public API is recorded for PMI Impact Malaria.
What industry is PMI Impact Malaria in?
PMI Impact Malaria's product category is Global Health Services / Malaria Control Programs. Its primary akta.pro industry code is HLAJAOAE, Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs), with a secondary code of BPADAIAA, Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs). Its NAICS code is 5417 and its SIC code is 8741.